Review

Nanomedicine targeting neuroinflammatory pathways in Alzheimer’s disease: a new frontier in inflammopharmacology

Sumit Kaushik Jamal E. Fatima Amatul Raheem Muazzam A. Barbhuiya A. T. Thirupathi Laliteshwar Pratap Singh Pathan Amanulla Khan T. Aparna S. Pramanik M. Shahid

Jul 2026 · InflammoPharmacology · Vol 34, pp. 5365 - 5404 · 1 citation · 225 references

Medicine

TL;DR

Comparative studies show that interventions based on nanocarrier-based therapies enhance therapeutic efficacy and safety profiles in preclinical AD models, and future directions include integrating AI-driven nano-design, gene and siRNA delivery, and precision neuropharmacology to enable personalized anti-inflammatory therapies.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease.

This review critically evaluates recent advances in NIM-based strategies for AD and PD, including intrinsically therapeutic nanomaterials, targeted delivery systems, and precision gene-regulatory platforms and discusses AI-driven nanomedicine optimization and advanced human-relevant models, including brain-on-a-chip sy...

Mohammed A. Abdel-Rasol · InflammoPharmacology · 0 citations

Review Open access Sep 2026

The Role of Neuroinflammation in Alzheimer's Disease: Molecular Mechanisms and Emerging Therapeutic Approaches

This review examines the molecular and cellular mechanisms through which neuroinflammation contributes to the progression of AD, with particular emphasis on microglial activation, TREM2 and soluble TREM2 (sTREM2) signaling, NLRP3 inflammasome activation, astrocyte–microglia interactions, and blood–brain barrier dysfunc...

Shreyansh Goswami · International Journal For Mu... · 0 citations

Review Sep 2026

Targeting cytokine-driven neuroinflammation in Alzheimer’s disease: mechanistic insights and pharmacological strategies

This review provides a comprehensive overview of cytokine-mediated neuroinflammation in Alzheimer's disease, focusing on the cellular sources of cytokine production within the brain, including microglia, astrocytes, neurons, and endothelial cells.

R. Wasim · InflammoPharmacology · 0 citations

Review Open access Jul 2026

Targeting Neutrophil Extracellular Traps in Neuroinflammation: A Therapeutic Perspective on Neurodegenerative Diseases

The protective and deleterious roles of NETs are investigated and how this knowledge may reveal new therapeutic strategies to modulate neurodegenerative diseases and preserve neural integrity are investigated, offering valuable insights for potential applications in clinical practice.

Iolanda Masalskiene Costa, Alexandre Kanashiro, Giovanna Siqueira Favi Barros et al. · Brain Science · 1 citation

Review Open access Jul 2026

Polyphenols and microglial dynamics in neurodegenerative diseases: mechanistic advances and therapeutic perspectives

This review consolidates current evidence regarding the mechanisms by which polyphenols modulate microglial phenotypic balance and polarization states and examines advanced delivery strategies designed to enhance their therapeutic efficacy in neuroinflammatory disorders.

Luping Liu, Huan Xiao, Jinhong Zhou et al. · PeerJ · 0 citations

Review Open access Aug 2026

From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease

This review summarizes the cellular and molecular basis of physiological and pathological neuron-immune communication in PD, highlighting the roles of microglial activation, astrocyte reactivity, adaptive immune responses, inflammatory signaling networks, and neurovascular dysfunction.

Shu Zhu, Zhongting Wang, Xiao-Xi Shi et al. · Materials Today Bio · 1 citation